Van Ginderachter JA - Search Results

1

Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancer.

Schoonooghe S, Laoui D, Van Ginderachter JA, Devoogdt N, Lahoutte T, De Baetselier P, Raes G. Schoonooghe S, et al. Among authors: van ginderachter ja. Immunobiology. 2012 Dec;217(12):1266-72. doi: 10.1016/j.imbio.2012.07.009. Epub 2012 Jul 21. Immunobiology. 2012. PMID: 22884356 Free article. Review.

2

Active antitumor immunotherapy, with or without B7-mediated costimulation, increases tumor progression in an immunogenic murine T cell lymphoma model.

Raes G, Van Ginderachter J, Liu YQ, Brys L, Thielemans K, De Baetselier P, Geldhof A. Raes G, et al. Cancer Immunol Immunother. 1998 Jan;45(5):257-65. doi: 10.1007/s002620050441. Cancer Immunol Immunother. 1998. PMID: 9439649 Free PMC article.

3

Effects of altered antigen processing on T-cell responses toward murine T-lymphomas.

Raes G, Van Ginderachter J, Devoogdt N, Geldhof A, De Baetselier P. Raes G, et al. Adv Exp Med Biol. 1998;451:211-5. doi: 10.1007/978-1-4615-5357-1_33. Adv Exp Med Biol. 1998. PMID: 10026874 No abstract available.

4

Effects of altered antigen processing on H-2Dk mediated NK inhibition in a murine T lymphoma model.

Van Ginderachter J, Raes G, Devoogdt N, De Baetselier F, Geldhof A. Van Ginderachter J, et al. Adv Exp Med Biol. 1998;451:237-40. doi: 10.1007/978-1-4615-5357-1_37. Adv Exp Med Biol. 1998. PMID: 10026878 No abstract available.

5

Multiple effects of transfection with interleukin 2 and/or interferon gamma on the behavior of mouse T lymphoma cells.

Geldhof AB, Van Ginderachter J, Vandersteen P, Raes G, De Baetselier P. Geldhof AB, et al. Clin Exp Metastasis. 1998 Jul;16(5):447-59. doi: 10.1023/a:1006585525399. Clin Exp Metastasis. 1998. PMID: 10091940

6

B7-1, IFN gamma and anti-CTLA-4 co-operate to prevent T-cell tolerization during immunotherapy against a murine T-lymphoma.

Van Ginderachter JA, Liu Y, Geldhof AB, Brijs L, Thielemans K, De Baetselier P, Raes G. Van Ginderachter JA, et al. Int J Cancer. 2000 Aug 15;87(4):539-47. Int J Cancer. 2000. PMID: 10918195

7

Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation.

Geldhof AB, Van Ginderachter JA, Liu Y, Noël W, Raes G, De Baetselier P. Geldhof AB, et al. Among authors: van ginderachter ja. Blood. 2002 Dec 1;100(12):4049-58. doi: 10.1182/blood-2001-11-0106. Epub 2002 Jul 25. Blood. 2002. PMID: 12393627 Free article.

8

Nitric oxide-independent CTL suppression during tumor progression: association with arginase-producing (M2) myeloid cells.

Liu Y, Van Ginderachter JA, Brys L, De Baetselier P, Raes G, Geldhof AB. Liu Y, et al. Among authors: van ginderachter ja. J Immunol. 2003 May 15;170(10):5064-74. doi: 10.4049/jimmunol.170.10.5064. J Immunol. 2003. PMID: 12734351

9

Ablation of NK cell function during tumor growth favors Type 2-associated macrophages, leading to suppressed CTL generation.

Geldhof AB, van Ginderachter JA, Liu Y, Noël W, de Baetselier P. Geldhof AB, et al. Among authors: van ginderachter ja. Clin Dev Immunol. 2003 Jun-Dec;10(2-4):71-81. doi: 10.1080/10446670310001626580. Clin Dev Immunol. 2003. PMID: 14768937 Free PMC article.

10

Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer.

Van Ginderachter JA, Meerschaut S, Liu Y, Brys L, De Groeve K, Hassanzadeh Ghassabeh G, Raes G, De Baetselier P. Van Ginderachter JA, et al. Blood. 2006 Jul 15;108(2):525-35. doi: 10.1182/blood-2005-09-3777. Epub 2006 Mar 9. Blood. 2006. PMID: 16527895 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters